Description
his assay uses the Luminex® 200™ platform.
Consider this assay for a comprehensive analysis of key cytokines and chemokines in equine models. The Equine Cytokine/Chemokine 23-Plex Discovery Assay® Array (EQD23) measures Eotaxin, GM-CSF, IL-6, IL-10, TNFα, and others, providing insights into immune response and inflammation from a small sample volume.
Ideal for studying inflammatory conditions, immune responses, and disease progression in horses, this assay is a powerful tool in helping to elucidate the role of various cytokines and chemokines in equine health. For instance, IL-6 and TNFα are critical in acute inflammation, while IL-10 is an important anti-inflammatory cytokine.
If you are exploring subtle immune responses or chronic inflammation, this assay offers detailed profiling of key biomarkers relevant to equine health and disease research.
Discover the power of precision with our assay, expertly designed for the Luminex® 200™ platform. This cutting-edge technology enables the simultaneous detection of multiple biomarkers from a minimal single sample, delivering comprehensive insights with unmatched efficiency. Streamline your research and unlock a new level of detail with our advanced multiplex assay solution.
Click here for information on shipping biological samples for Discovery Assays